{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:02:16Z","timestamp":1777514536386,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.vaccine.2003.11.004","type":"journal-article","created":{"date-parts":[[2003,12,6]],"date-time":"2003-12-06T11:47:31Z","timestamp":1070711251000},"page":"1899-1902","source":"Crossref","is-referenced-by-count":15,"title":["The prevalence of anti-rubella antibodies in women of childbearing age in Poland"],"prefix":"10.1016","volume":"22","author":[{"given":"T.","family":"Wysoki\u00f1ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Janaszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bucholc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gorska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gniadek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Slusarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rawicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.11.004_BIB1","unstructured":"Measles, mumps and rubella vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunisation Practices (ACIP). Morbidity Mortality Weekly Rep 1998;(47):1\u201357."},{"key":"10.1016\/j.vaccine.2003.11.004_BIB2","unstructured":"Preventing congenital rubella syndrome. Weekly Epidemiol Rec 2000;75(36):289\u201396."},{"key":"10.1016\/j.vaccine.2003.11.004_BIB3","doi-asserted-by":"crossref","unstructured":"Mitchell LA, Ho MK, Rogers JE, Tingle AJ, Marusyk RG, Weber JM, et al. Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals, J Clin Microbiol 1996:2210\u201318.","DOI":"10.1128\/JCM.34.9.2210-2218.1996"},{"key":"10.1016\/j.vaccine.2003.11.004_BIB4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1471-0528.1989.tb03340.x","article-title":"Rubella infection in pregnancy: remaining problems","volume":"96","author":"Miller","year":"1989","journal-title":"Br. J. Obstetr. Gynaecol"},{"key":"10.1016\/j.vaccine.2003.11.004_BIB5","unstructured":"Imbs D, Rudnicka H, Prus A. Natural and postvaccination seroconversion for rubella virus among female medicine women working in medical institutions. Przeg Epid 1980;34:163\u201366."},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.004_BIB6","first-page":"303","article-title":"Seroepidemiological study on cytomegaly and rubella at pregnant women and prostitutes","volume":"XLVI","author":"Kara\u015b","year":"1992","journal-title":"Przeg. Epid"},{"issue":"11","key":"10.1016\/j.vaccine.2003.11.004_BIB7","first-page":"815","article-title":"Rubella, the problem of women in procreative life time","volume":"70","author":"Wiercinska-Drapa\u0142o","year":"1999","journal-title":"Gin Poland"},{"key":"10.1016\/j.vaccine.2003.11.004_BIB8","unstructured":"Kope\u0107 J, Zag\u00f3rniak-Nowosielska I. Incidence of rubella antibodies and the results of vaccination against rubella in young women. Przeg Epid 1994;XLVIII(4):475\u201379."},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.004_BIB9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0264-410X(94)90009-4","article-title":"Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults","volume":"12","author":"Christenson","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.004_BIB10","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/S0264-410X(00)00139-0","article-title":"Duration of rubella immunity induced by two-dose measles","volume":"18","author":"Davidkin","year":"2000","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2003.11.004_BIB11","first-page":"1791","article-title":"Twenty-three-year follow-up study of rubella antibodies after immunization in a closed population, and serological response to revaccination","volume":"16","author":"Asaki","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.004_BIB12","unstructured":"Kajfasz P, Rubella. Terapia i Leki 1992;XX\/XLII(9):236\u201345."},{"key":"10.1016\/j.vaccine.2003.11.004_BIB13","unstructured":"Go\u0142\u0229biowska-Sitarska. Department of Epidemiology, National Institute of Hygiene, Warsaw [unpublished data]."},{"issue":"18","key":"10.1016\/j.vaccine.2003.11.004_BIB14","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/0264-410X(95)00143-O","article-title":"Immunity to rubella before and after vaccination against measles mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 month","volume":"13","author":"Bottiger","year":"1995","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2003.11.004_BIB15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/clinids\/7.Supplement_1.S80","article-title":"Persistence of vaccine induced immune responses to rubella. Comparison with natural infection","volume":"7","author":"Hartmann","year":"1985","journal-title":"Rev. Infect. Dis"},{"key":"10.1016\/j.vaccine.2003.11.004_BIB16","doi-asserted-by":"crossref","unstructured":"Morgan-Capner P, Hodgran J, Hambling HH. Detection of rubella-specific IgM in subclinical rubella infection in pregnancy. Lancet 1985;i(246):244\u201346.","DOI":"10.1016\/S0140-6736(85)91027-X"},{"key":"10.1016\/j.vaccine.2003.11.004_BIB17","doi-asserted-by":"crossref","unstructured":"Terada K, Niizuma T, Daimon I, Kataoka. Accumulative vaccination rate of rubella and positive antibody rate of Japan\u2014future problems with rubella. Kansenshogaku Zassi 1999;73(10):1038\u201341.","DOI":"10.11150\/kansenshogakuzasshi1970.73.1038"},{"key":"10.1016\/j.vaccine.2003.11.004_BIB18","first-page":"337","article-title":"Subclinical rubella reinfection in vaccinated women with rubella-specific IgM response during pregnancy and transmission of virus to the fetus","volume":"17","author":"Forsgren","year":"1985","journal-title":"Scand. J. Infect. Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T19:27:10Z","timestamp":1585337230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03007795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":18,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0264410X03007795"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}